Your browser doesn't support javascript.
loading
Genetic modification in Malaysia and India: current regulatory framework and the special case of non-transformative RNAi in agriculture.
Darsan Singh, Jasdeep Kaur; Mat Jalaluddin, Nurzatil Sharleeza; Sanan-Mishra, Neeti; Harikrishna, Jennifer Ann.
Afiliação
  • Darsan Singh JK; Centre for Research in Biotechnology for Agriculture (CEBAR), Level 3, Research Management and Innovation Complex, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia.
  • Mat Jalaluddin NS; Faculty of Science, Institute of Biological Sciences, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia.
  • Sanan-Mishra N; Centre for Research in Biotechnology for Agriculture (CEBAR), Level 3, Research Management and Innovation Complex, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia.
  • Harikrishna JA; International Centre for Genetic Engineering and Biotechnology (ICGEB), Aruna Asaf Ali Marg, New Delhi, Delhi, 110067, India.
Plant Cell Rep ; 38(12): 1449-1463, 2019 Dec.
Article em En | MEDLINE | ID: mdl-31350570
Recent developments in modern biotechnology such as the use of RNA interference (RNAi) have broadened the scope of crop genetic modification. RNAi strategies have led to significant achievements in crop protection against biotic and abiotic stresses, modification of plant traits, and yield improvement. As RNAi-derived varieties of crops become more useful in the field, it is important to examine the capacity of current regulatory systems to deal with such varieties, and to determine if changes are needed to improve the existing frameworks. We review the biosafety frameworks from the perspective of developing countries that are increasingly involved in modern biotechnology research, including RNAi applications, and make some recommendations. Malaysia and India have approved laws regulating living modified organisms and products thereof, highlighting that the use of any genetically modified step requires regulatory scrutiny. In view of production methods for exogenously applied double-stranded RNAs and potential risks from the resulting double-stranded RNA-based products, we argue that a process-based system may be inappropriate for the non-transformative RNAi technology. We here propose that the current legislation needs rewording to take account of the non-transgenic RNAi technology, and discuss the best alternative for regulatory systems in India and Malaysia in comparison with the existing frameworks in other countries.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article